Arthritis, Psoriatic Clinical Trials

11 recruiting

Arthritis, Psoriatic Trials at a Glance

11 actively recruiting trials for arthritis, psoriatic are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Phase 3 with 2 trials, with the heaviest enrollment activity in Budapest, Charlotte, and A Coruña. Lead sponsors running arthritis, psoriatic studies include Janssen Research & Development, LLC, Centre Hospitalier Régional d'Orléans, and AndHealth.

Browse arthritis, psoriatic trials by phase

Treatments under study

About Arthritis, Psoriatic Clinical Trials

Looking for clinical trials for Arthritis, Psoriatic? There are currently 11 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Arthritis, Psoriatic trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Arthritis, Psoriatic clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Phase 3

Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response

Arthritis, Psoriatic
MoonLake Immunotherapeutics AG600 enrolled135 locationsNCT06641089
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Icotrokinra (JNJ-77242113) in Biologic-experienced Participants With Active Psoriatic Arthritis

Arthritis, Psoriatic
Janssen Research & Development, LLC750 enrolled214 locationsNCT06807424
Recruiting
Phase 2

A Study to Evaluate the Efficacy and Safety of JNJ-88545223 for the Treatment of Participants With Active Psoriatic Arthritis

Arthritis, Psoriatic
Janssen Research & Development, LLC240 enrolled40 locationsNCT07321873
Recruiting
Phase 4

A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)

Arthritis, Psoriatic
Johnson & Johnson Private Limited100 enrolled9 locationsNCT07141004
Recruiting

A Study of Guselkumab in Participants With Psoriatic Arthritis (PsA) in a Real-World Setting

Arthritis, Psoriatic
Janssen Research & Development, LLC200 enrolled21 locationsNCT07220824
Recruiting

Effects of Phytocannabinoids on Immune Response and Autophagy During Chronic Immune-mediated Inflammatory Diseases

Inflammatory Bowel DiseasesArthritis, RheumatoidSjogren's Syndrome+4 more
Centre Hospitalier Régional d'Orléans100 enrolled1 locationNCT06842316
Recruiting
Phase 1

Evaluation of Allocetra by Intra-articular Injection for the Treatment of Psoriatic Arthritis

Arthritis, Psoriatic
Enlivex Therapeutics Ltd.6 enrolled4 locationsNCT06522035
Recruiting
Not Applicable

Influence of Sodium Intake in spondyLoarthriTes

Arthritis, PsoriaticSpondyloarthritis, Axial
Centre Hospitalier Universitaire de Besancon250 enrolled4 locationsNCT06259890
Recruiting

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

Arthritis, RheumatoidArthritis, PsoriaticSpondylitis, Ankylosing
Aalborg University Hospital120 enrolled1 locationNCT04731831
Recruiting

IMPACT - AndHealth Autoimmune Research Registry

Ankylosing SpondylitisPsoriasisArthritis, Rheumatoid+2 more
AndHealth2,500 enrolled1 locationNCT05883371
Recruiting

Novel Complex Radiodiagnostics of Peripherial Arthropathies

Arthritis, RheumatoidArthritis, PsoriaticCrystal Arthropathies
Semmelweis University500 enrolled3 locationsNCT05657847